Increased bone volume and correction of HYP mouse hypophosphatemia in the Klotho/HYP mouse

Endocrinology

Volumn 151, Issue 2, 2010, Pages 492-501

  Brownstein, Catherine A ^a   Zhang, Junhui ^a   Stillman, Althea ^a   Ellis, Bruce ^a   Troiano, Nancy ^a   Adams, Douglas J ^b   Gundberg, Caren M ^a   Lifton, Richard P ^a   Carpenter, Thomas O ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCITRIOL; CALCIUM; FIBROBLAST GROWTH FACTOR 23; GENOMIC DNA; KLOTHO PROTEIN; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE; PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; BLOOD SAMPLING; BONE DENSITY; BONE TURNOVER; CALCIUM EXCRETION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE DISRUPTION; GENOTYPE; HORMONE BLOOD LEVEL; HYPOPHOSPHATEMIA; LIFESPAN; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NONHUMAN; NULL ALLELE; PHENOTYPE; PHOSPHATE URINE LEVEL; PRIORITY JOURNAL; TRABECULAR BONE; VITAMIN BLOOD LEVEL;

ANIMALS; CALCIUM; CROSSES, GENETIC; DNA PRIMERS; FEMALE; FEMUR; GENOTYPE; GLUCURONIDASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; MALE; MICE; MICE, KNOCKOUT; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; TIBIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 74949106383     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0564     Document Type: Article

References (28)

1. Eicher EM, Southard JL, Scriver CR, Glorieux FH 1976 Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. Proc Natl Acad Sci USA 73:4667-4671
2. Strom TM, Francis F, Lorenz B, Böddrich A, Econs MJ, Lehrach H, Meitinger T 1997 Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia. Hum Mol Genet 6:165-171
3. Beck L, Soumounou Y, Martel J, Krishnamurthy G, Gauthier C, Goodyer CG, Tenenhouse HS 1997 Pex/PEX tissue distribution and evidence for a deletion in the 3′ region of the Pex gene in X-linked hypophosphatemic mice. J Clin Invest 99:1200-1209
4. The HYP Consortium 1995 A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 11:130-136
5. Strewler GJ 2001 FGF23, hypophosphatemia, and rickets: has phosphatonin been found? Proc Natl Acad Sci USA 98:5945-5946
6. Bai XY, Miao D, Goltzman D, Karaplis AC 2003 The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency. J Biol Chem 278:9843-9849
7. Kumar R 2000 Tumor-induced osteomalacia and the regulation of phosphate homeostasis. Bone 27:333-338
8. Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S, Yamashita T 2006 Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444:770-774
9. Shiraki-Iida T, Aizawa H, Matsumura Y, Sekine S, Iida A, Anazawa H, Nagai R, Kuro-o M, Nabeshima Y 1998 Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein. FEBS Lett 424:6-10
10. Matsumura Y, Aizawa H, Shiraki-Iida T, Nagai R, Kuro-o M, Nabeshima Y 1998 Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem Biophys Res Commun 242:626-630
11. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI 1997 Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45-51
12. Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, Baum MG, Schiavi S, Hu MC, Moe OW, Kuro-oM 2006 Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 281:6120-6123
13. Gundberg CM, Clough ME, Carpenter TO 1992 Development and validation of a radioimmunoassay for mouse osteocalcin: paradoxical response in the Hyp mouse. Endocrinology 130:1909-1915
14. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610
15. Yoshida T, Fujimori T, Nabeshima Y 2002 Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1 α-hydroxylase gene. Endocrinology 143:683-689
16. Posillico JT, Lobaugh B, Muhlbaier LH, Drezner MK 1985 Abnormal parathyroid function in the X-linked hypophosphatemic mouse. Calcif Tissue Int 37:418-422
17. Meyer Jr RA, Meyer MH, Gray RW, Bruns ME 1987 Evidence that low plasma 1,25-dihydroxyvitamin D causes intestinal malabsorption of calcium and phosphate in juvenile X-linked hypophosphatemic mice. J Bone Miner Res 2:67-82
18. Strom TM, Jüppner H 2008 PHEX, FGF23, DMP1 and beyond. Curr Opin Nephrol Hypertens 17:357-362
19. Fukumoto S, Yamashita T 2007 FGF23 is a hormone-regulating phosphate metabolism: unique biological characteristics of FGF23. Bone 40:1190-1195
20. Tenenhouse HS, Martel J, Gauthier C, Segawa H, Miyamoto K 2003 Differential effects of Npt2a gene ablation and X-linked Hyp mutation on renal expression of Npt2c. Am J Physiol Renal Physiol 285:F1271-F1278
21. Benet-Pagès A, Lorenz-Depiereux B, Zischka H, White KE, Econs MJ, Strom TM 2004 FGF23 is processed by proprotein convertases but not by PHEX. Bone 35:455-462
22. Liu S, Zhou J, Tang W, Jiang X, Rowe DW, Quarles LD 2006 Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab 291:E38-E49
23. Razzaque MS, Lanske B 2007 The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis. J Endocrinol 194:1-10
24. Kawaguchi H, Manabe N, Miyaura C, Chikuda H, Nakamura K, Kuro-o M 1999 Independent impairment of osteoblast and osteoclast differentiation in klotho mouse exhibiting low-turnover osteopenia. J Clin Invest 104:229-237
25. Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, McGuinness OP, Chikuda H, Yamaguchi M, Kawaguchi H, Shimomura I, Takayama Y, Herz J, Kahn CR, Rosenblatt KP, Kuro-o M 2005 Suppression of aging in mice by the hormone Klotho. Science 309:1829-1833
26. Perwad F, Zhang MY, Tenenhouse HS, Portale AA 2007 Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1 α-hydroxylase expression in vitro. Am J Physiol Renal Physiol 293:F1577-F1583
27. Imai M, Ishikawa K, Matsukawa N, Kida I, Ohta J, Ikushima M, Chihara Y, Rui X, Rakugi H, Ogihara T 2004 Klotho protein activates the PKC pathway in the kidney and testis and suppresses 25-hydroxyvitamin D3 1 α-hydroxylase gene expression. Endocrine 25:229-234
28. Brownstein CA, Adler F, Nelson-Williams C, Iijima J, Li P, Imura A, Nabeshima Y, Reyes-Mugica M, Carpenter TO, Lifton RP 2008 A translocation causing increased α-klotho level results in hypophosphatemic rickets and hyperparathyroidism. Proc Natl Acad Sci USA 105:3455-3460